- Home
- BSBK vs PMN Comparison
BSBK vs PMN Comparison
Compare BSBK & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBK | PMN |
|---|---|---|
| Founded | 1893 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.0M | 115.5M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BSBK | PMN |
|---|---|---|
| Price | $9.06 | $13.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 8.8K | ★ 30.2K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 200.00 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $151.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.90 | $0.29 |
| 52 Week High | $9.49 | $27.40 |
Technical Indicators
Market Signals| Indicator | BSBK | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 73.14 |
| Support Level | $8.83 | $10.55 |
| Resistance Level | $9.29 | $13.80 |
| Average True Range (ATR) | 0.12 | 0.78 |
| MACD | -0.02 | 0.40 |
| Stochastic Oscillator | 62.50 | 77.91 |
Price Performance
Historical ComparisonAbout BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey. The Company operates one reportable segment of business, retail banking. Through its community banking segment, the Company provides a broad range of retail and commercial banking services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.